Ingersoll Rand Inc. vs Biogen Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Ingersoll Rand Inc.
$31.5B
μμ #308
Biogen Inc.
$31.9B
μμ #305
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Ingersoll Rand Inc.μ΄(κ°) 2024λ κΉμ§ Biogen Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Biogen Inc.μ΄(κ°) 2026λ κΉμ§ Ingersoll Rand Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Ingersoll Rand Inc. | Biogen Inc. | μ λ |
|---|---|---|---|
| 2026 | $31.5B | $31.9B | Biogen Inc. |
| 2025 | $31.0B | $26.0B | Ingersoll Rand Inc. |
| 2024 | $35.3B | $22.6B | Ingersoll Rand Inc. |
| 2023 | $30.2B | $38.2B | Biogen Inc. |
| 2022 | $20.4B | $40.9B | Biogen Inc. |
| 2021 | $24.1B | $35.4B | Biogen Inc. |
| 2020 | $17.7B | $36.2B | Biogen Inc. |
| 2019 | $14.0B | $43.8B | Biogen Inc. |
| 2018 | $7.4B | $44.4B | Biogen Inc. |
| 2017 | $12.3B | $47.0B | Biogen Inc. |